0
Your cart

Your cart is empty

Books > Social sciences > Politics & government > Central government > Central government policies

Buy Now

Overdose - How Excessive Government Regulation Stifles Pharmaceutical Innovation (Paperback) Loot Price: R1,425
Discovery Miles 14 250
Overdose - How Excessive Government Regulation Stifles Pharmaceutical Innovation (Paperback): Richard A. Epstein

Overdose - How Excessive Government Regulation Stifles Pharmaceutical Innovation (Paperback)

Richard A. Epstein

 (sign in to rate)
Loot Price R1,425 Discovery Miles 14 250 | Repayment Terms: R134 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

An analysis of how we regulate the pharmaceutical industry: are we protecting patients or blocking the development of useful new drugs? This book is the first to offer a comprehensive examination of the pharmaceutical industry by following the tortuous course of a new drug as it progresses from early development to final delivery. Richard A. Epstein looks closely at the regulatory framework that surrounds all aspects of making pharmaceutical products today, and he assesses which current legal and regulatory practices make sense and which have gone awry. While critics of pharmaceutical companies call for ever more stringent controls on virtually every aspect of drug development and approval, Epstein cautions that the effect of such an approach will be to stifle pharmaceutical innovation and slow the delivery of beneficial treatments to the patients who need them. The author considers an array of challenges that confront the industry--conflicts of interest among government, academe, and the drug companies; intellectual property rights that govern patents; FDA regulation; pricing disputes; marketing practices; and liability issues, including those brought to light in the recent VIOXX case. Epstein argues that to ensure the continuing creativity, efficiency, and success of the pharmaceutical industry, the best system will feature strong property rights and clearly enforceable contracts, with minimal regulatory and judicial interference.

General

Imprint: Yale University Press
Country of origin: United States
Release date: October 2008
First published: December 2008
Authors: Richard A. Epstein
Dimensions: 235 x 156 x 17mm (L x W x T)
Format: Paperback - Trade
Pages: 296
ISBN-13: 978-0-300-14326-3
Categories: Books > Social sciences > Politics & government > Central government > Central government policies
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
LSN: 0-300-14326-5
Barcode: 9780300143263

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners